MeCure rebounds as expansion begins to pay off

MeCure Industries Plc’s latest audited results tell a two-year story of strain and payoff. In 2024, the pharmaceutical company grew revenue by 45 percent to N46.03 billion, yet profit after tax fell 20 percent to N2.3 billion. Twelve months later, profit surged 183 percent to N6.5 billion as re

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```